Takeda Completes Enrollment of Large Global Phase 3 Trial for Dengue Vaccine Candidate
Takeda Pharmaceutical Company Limited announced that it has completed enrollment of 20,100 children and adolescents ages 4 through 16in its...
Aurinia Announces Development Plans for Voclosporin in Europe and Japan
Aurinia Pharmaceuticals Inc announced the outcome of discussions with both the EMA and the PMDA in Japan regarding the development...
Teva announces FDA approval of Austedo tablets for chorea associated with huntington’s disease
Teva Pharmaceutical Industries Ltd. announced that the U.S. FDA has approved AUSTEDO™ (deutetrabenazine) tablets for the treatment of chorea associated...
College of Pharmacy, IBM help next generation of pharmacists utilize Business Intelligence Technologies
IBM and Lipscomb University College of Pharmacy announced an initiative to help train the next-generation of pharmacists on business analytics...
Ascendis Pharma A/S Showcases New Data on Rare Disease Product Pipeline at ENDO 2017
Ascendis Pharma A/S ,biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases...
Glenmark Pharma reports positive results from a Phase 3 trial of GSP 301
Glenmark Pharmaceuticals, a global pharmaceutical company announced positive results for GSP 301, an investigational fixed-dose combination of mometasone furoate (25...
Intralytix and BioPhage partner to develop bacteriophage treatments of human wounds infected with S. aureus
Intralytix, Inc. announced that the Company is partnering with BioPhage Therapeutics Limited to develop and commercialize topical bacteriophage treatments of...
Neurim Pharma Grants Exeltis Marketing Rights For Paediatric Prolonged-Release Melatonin in Spain
Neurim Pharmaceuticals and Exeltis announced a license agreement in which Exeltis will obtain exclusive marketing rights for Neurim’s new Rx...
Icertis Extends Leadership in Pharmaceutical Market with Update to Clinical Trial Agreement
Icertis, the leading provider of enterprise contract management in the cloud announced an upgrade to the Icertis Clinical Trial Agreement...
Medigene Revises Collaboration With Mitsui Norin regarding its drug Veregen
Medigene had contracted Mitsui Norin since 2005 for manufacturing and supplying the active pharmaceutical ingredient (API) of Veregen®. Based on...
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.